NeoQ10 Disease Interactions
There are 2 disease interactions with NeoQ10 (ubiquinone / vitamin e).
Vitamin E (applies to NeoQ10) hepatobiliary dysfunction
Major Potential Hazard, High plausibility. Applicable conditions: Liver Disease, Biliary Obstruction
Vitamin E is fat soluble and many oral formulations require bile for adequate intestinal absorption. Hepatic and/or biliary dysfunction decrease the absorption of vitamin E. Water- miscible vitamin E formulations may be better absorbed from the GI tract under these conditions. Vitamin E is metabolized by the liver and primarily excreted in bile and feces. Hepatic and/or biliary impairment can alter the metabolic and therapeutic activity of vitamin E.
Vitamin E (applies to NeoQ10) malabsorption syndromes
Minor Potential Hazard, High plausibility.
Vitamin E is readily absorbed from the intestinal tract in the presence of bile. Prolonged fat malabsorption (cystic fibrosis, hepatic cirrhosis, sprue) or malabsorption syndromes (celiac disease, GI resection) can decrease the absorption of many oral formulations of vitamin E. A water- miscible formulation of vitamin E may be better absorbed in these conditions.
Switch to professional interaction data
NeoQ10 drug interactions
There are 251 drug interactions with NeoQ10 (ubiquinone / vitamin e).
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.